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Abstract 
Prolonged immobility is harmful with rapid reductions in muscle mass, bone mineral density and impairment in other 
body systems evident within the first week of bed rest which is further exacerbated in individuals with critical illness. 
Our understanding of the aetiology and secondary consequences of prolonged immobilization in the critically ill is 
improving with recent and ongoing research to establish the cause, effect, and best treatment options. This review 
aims to describe the current literature on bed rest models for examining immobilization-induced changes in the 
musculoskeletal system and pathophysiology of immobilisation in critical illness including examination of intracellular 
signalling processes involved. Finally, the review examines the current barriers to early activity and mobilization and 
potential rehabilitation strategies, which are being, investigated which may reverse the effects of prolonged bed rest. 
Addressing the deleterious effects of immobilization is a major step in treatment and prevention of the public health 
issue, that is, critical illness survivorship.
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Background
Advances in medical knowledge and technology have led 
to improvements in survival rates following critical ill-
ness in the past decade [1, 2]. Intensive care unit (ICU) 
discharge no longer marks the endpoint of critical illness 
[3]; rather the new challenge for the 21st century is the 
issue of survivorship [4]. The burden of survivorship has 
been examined in longitudinal studies where it is evident 
that patients suffer ongoing muscle weakness, impaired 
physical functioning as well as neurocognitive and psy-
chiatric symptoms collectively known as “post-intensive 
care syndrome” [1, 5–7].
Increasing numbers of patients are admitted to critical 
care, with this rise projected to continue as new treat-
ments emerge, expectations for care change, and popula-
tion demographics and patterns of disease alter. In ICU, 
patients traditionally were heavily sedated and the focus 
was on maintaining maximum physiological stability of 
the organ systems with prolonged bed rest a necessary 
by-product [8]. This is now being challenged as there is 
growing awareness that these management strategies 
may impact on long-term outcomes for survivors [9]. 
Developing a greater understanding of aetiology, mecha-
nisms, potential treatment and preventative strategies 
is important for minimization of morbidity associated 
with survival for patients and their families including the 
potential economic burden on the health-care system.
Impact of bed rest on the body systems from “bed rest” 
models
Bed rest was first introduced as a medical treatment in 
the 19th century to minimize the metabolic demand on 
the body and enable a focus on healing and rest to pro-
mote recovery [10]. However, lack of physical activity 
and prolonged bed rest have significant consequences 
on musculoskeletal, cardiovascular, respiratory, integu-
mentary and cognitive systems and may be associated 
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with harm [11]. Bed rest models are commonly used to 
simulate the effects of space flight and physical inactivity 
[12, 13]. Anti-gravity muscles such as leg extensors and 
trunk musculature are preferentially affected by the loss 
of mechanical loading compared to hand and upper limb 
musculature [12, 14]. Three bed rest models are com-
monly used for muscle wasting research.
Limb suspension
Commonly achieved in humans using a sling and 
crutches (occasionally with bespoke shoes), a limb sus-
pension model was used by de Boer et al. [15]. In a 23-day 
program, muscle mass was seen to reduce by 5.2 % within 
the first 2 weeks and subjects lost in total 10 % of quadri-
ceps muscle mass by 23-days. Of note, this was not par-
alleled by continued up regulation of the intracellular 
signalling molecules driving muscle protein breakdown 
(MPB). Muscle activity across the knee joint of the sus-
pended limb is not suppressed, suggesting that this is not 
the most effective model of lower limb immobilization 
[16].
Limb casting
Limb casting, preventing knee joint movement, can 
induce further immobilization. Subjects are usually 
allowed to continue ambulation on crutches. Whilst 
numbers of subjects have been relatively small, decreases 
in muscle mass have been noted in several studies 
between 10 and 14  days [17, 18]. Gibson demonstrated 
decreased muscle protein synthesis (MPS) using a limb 
casting method, albeit over a longer period of 6 weeks 
[19, 20].
Bed rest and microgravity
The most commonly used model, bed rest has been 
shown to cause muscle wasting within 10 days in healthy 
older adults [21]. However, when a head-down position 
is added (simulating microgravity), Ferrando et al. dem-
onstrated loss of muscle mass within 7  days [22]. This 
combination has been used repeatedly to simulate mus-
cle unloading in space flight unlike limb casting and limb 
suspension; bed rest ±  microgravity induces the multi-
system effects of immobilization [16, 22]. With immo-
bilization, in addition to an overall reduction in muscle 
mass, there is a reduction in muscle fibre size [12, 14] 
with accelerated reduction in the strength of fast-twitch 
(type II) fibres compared to slow-twitch (type I) fibres 
which rely on oxidative metabolic processes, result-
ing in lower fatigue resistance capacity [12, 23]. There is 
not only a loss of muscle force generation capacity due 
to reduction in muscle mass, contractile proteins, but 
also alterations in muscle electromyographic activity. 
This highlights changes occur in terms of the neural or 
muscle membrane excitability to enable potentiation of 
a muscle contraction [24, 25]. Immobility also increases 
the production of pro-inflammatory cytokines and reac-
tive oxygen species with subsequent muscle proteolysis 
promoting overall muscle loss [26, 27]. As a result of loss 
of muscle mass, up to 40 % of muscle strength can be lost 
within the first week of immobilization [12]. Bed rest 
studies have demonstrated preferential atrophy of the 
anti-gravity muscle groups such as soleus, back extensors 
and quadriceps musculature [12, 14]. Fibre atrophy may 
relate to the initial fibre size, which may explain partly 
why anti-gravity musculature which consist primarily of 
Type I fibres preferentially atrophy. Loss of muscle con-
tractile protein and fibre size is only one component to 
the loss of force generation capability, and other factors 
which interplay include neural, hormonal, and cellular 
signalling processes.
Skeletal tissue also responds rapidly to changes in 
mechanical loading during bed rest [12]. There is greater 
bony resorption than formation, resulting in a net reduc-
tion in bone integrity and demineralization [14] which 
preferentially affects trabecular bone [12] and may there-
fore place an individual at higher risk of fractures and 
future morbidity and mortality. Changes in skeletal integ-
rity occur at a slower rate compared to muscular changes, 
with one study reporting a 1 % reduction in bone density 
within the vertebral column after 1 week of immobility 
[28]. A recent study demonstrated early and rapid bone 
demineralization in individuals with acute respiratory 
distress syndrome and a concomitant increase in fracture 
risk by ~20 % [29]. This is the first study to demonstrate 
this within the critical care environment [29].
Other organs systems are affected too by immobiliza-
tion. A full discussion on these is beyond the scope of 
this review. Inactivity and prolonged bed rest have also 
been shown to result in cardiac deconditioning affect-
ing both the central and peripheral cardiovascular sys-
tems. Stroke volume has been shown to be reduced by 
30 % within the first month of bed rest, with an associ-
ated increase in resting heart rate, and signs of ortho-
static intolerance can develop within 72  h of inactivity 
[30–33]. These changes are mediated to a large extent by 
a reduction in blood volume [34]. The respiratory system 
is also negatively affected with development of atelec-
tasis and increased likelihood of developing respiratory 
complications such as pneumonia [32]. Other secondary 
consequences include increased risk of thromboembolic 
events, pressure ulcers, insulin resistance, and develop-
ment of delirium or cognitive processing impairments 
and alterations in sleep patterns [26, 32, 35]. While the 
majority of immobility related pathophysiology nor-
malizes upon mobilization and reduction in sedation, 
the effects on skeletal muscle do not. Instead muscle 
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wasting results in muscle weakness, which in critical ill-
ness is termed Intensive Care Unit-Acquired weakness 
(ICU-AW).
Intensive care unit‑acquired weakness—incidence 
and diagnosis
Intensive care unit-acquired weakness is defined as clini-
cally detectable weakness in which there is no plausible 
aetiology other than critical illness [36] and is character-
ized by bilateral symmetrical flaccid paresis of the limbs 
[37]. It is associated with prolonged hospitalization, 
delayed weaning and increased mortality [38–40]. The 
reported incidence of ICU-AW varies depending on the 
patient population, timing of assessment and diagnos-
tic methods used (i.e. electrophysiological, histological 
or clinical) [41–44]. In one prospective study, ICU-AW 
was clinically diagnosed in 25  % of patients receiving 
mechanical ventilation for greater than 7 days [41], and 
in another study using electrophysiological testing, the 
incidence was 58 % [45]. The incidence of ICU-AW is sig-
nificantly higher in individuals with sepsis and has been 
reported to be as high as 50–100 % [46–49]. The diagno-
sis of ICU-AW is primarily clinical based on manual mus-
cle strength testing using the Medical Research Council 
sum score to assess bilaterally six muscle groups in the 
upper and lower limb [50]. A score of less than 48 out of 
60 is considered indicative of ICU-AW [51]. A two-tier 
approach to screening for the presence of ICU-AW has 
been recommended involving (1) evaluation of handgrip 
strength and (2) manual muscle strength testing using an 
isometric approach with the Medical Research Council 
sum score [52]. Additional testing can be performed such 
as electromyography, nerve conduction or muscle biopsy 
to determine the presence of neuropathy, myopathy or 
neuromyopathy [50]. However, these investigations are 
not routinely available in every clinical setting and are 
more time-consuming, invasive and costly to perform.
Non‑immobilization aetiology and risk factors for the 
development of ICU‑AW
The aetiology by which critical illness leads to muscle 
weakness is complex and involves several inter-related 
processes [53]. Investigation into the risk factors for the 
development of ICU-AW have been limited by poor study 
design (predominantly retrospective chart review within 
a single centre), small sample sizes, lack of standardized 
definitions and heterogeneity of the ICU cohorts, thus 
limiting the comparability between studies. A number of 
independent risk factors have been correlated with the 
development of ICU-AW including sepsis [54]; the pres-
ence of organ failure involving two or more organs and 
severity of illness [41, 55–58]; duration of mechanical 
ventilation [41]; ICU length of stay [44, 54]; female gender 
[41]; hyperglycaemia [44, 59] and immobility [41, 53, 60]. 
Sepsis additionally has adverse effects on mitochondrial 
function, which may have a further compounding effect 
on muscle wasting [61]. Pathophysiologically immobility 
and local and systemic inflammation are believed to act 
synergistically to promote significant muscle loss in the 
critically ill patient [53]. Whilst the use of neuromuscular 
blockade agents has been previously cited as a risk factor, 
there remains no evidence for its association [62]—the 
only randomized trial performed showed no increase in 
ICU-AW following 48 h of paralysis [63], even in patients 
receiving concomitant steroids [64]. However, the rela-
tive contribution of each of these factors has not yet been 
established, and a full discussion on non-immobilization-
related risk factors is beyond the scope of this review.
Sedation—a risk factor that potentially augments the 
pathophysiology of immobilization
Sedation remains an unknown factor in immobilization-
related muscle remodelling. Propofol and benzodiaz-
epines positively modulate the inhibitory function of the 
neurotransmitter gamma-aminobutyric acid (GABA) [65, 
66]. GABA facilitates the opening of the voltage-gated 
chloride channels in skeletal muscle, decreasing muscle 
excitability [66, 67]. Barbiturates and ketamine attenu-
ate the response of excitatory neurotransmitters such as 
glutamate, decreasing muscle tone by acting on motor 
associated neurones in the spinal cord via N-methyl-
d-aspartate (NMDA) receptors [66, 68, 69]. Recently, 
NMDA receptors have been discovered on the post-syn-
aptic endplate in skeletal muscle [70]. Skeletal muscle is 
believed to require active support from neuronal trophic 
factors such as neuregulin to maintain mass. Pharmaco-
logical attenuation of their transport by sedatives may 
compound muscle wasting [71, 72]. Thus, continued 
sedation is likely to have a greater effect on muscle atro-
phy and weakness than “conscious immobility” in the 
absence of sedation (Fig. 1). It is reasonable to postulate 
Fig. 1 The immobility period. Providing conceptualization of the rate 
of muscle wasting in different states of immobilization based on the 
research literature
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that the beneficial effects of minimizing sedation [73–76] 
might, at least in part, be due to a relative maintenance of 
muscle mass and function. This hypothesis has yet to be 
formally examined. There are intrinsic difficulties in sep-
arating the effects of sedatives from bed rest in humans 
and ethical issues in animal studies. It may be that cell 
culture work, using human myocytes, is required so as to 
advance understanding of this issue.
The pathophysiological effect of immobilization 
on skeletal muscle in critical illness
Skeletal muscle mass is regulated by a balance between 
MPS and MPB [77]. In a 70  kg human, approximately 
280  g of protein is synthesized and degraded each day 
[78]. The two processes are linked, in a fashion described 
by Millward as facilitative or adaptive processes, whereby 
MPS facilitates (allows modulation of muscle mass) 
and MPB adapts (limiting said modulation) [79]. When 
exposed to an anabolic stimulus, MPS rises. MPB rises 
too, but to a lesser amount, resulting in a net synthetic 
balance. In response to an anti-anabolic stimulus, MPS 
decreases and MPB decreases to a lesser degree, resulting 
in a net breakdown.
The interaction between critical illness and bed rest 
may result in greater muscle loss compared to bed rest 
alone [26, 53]. The musculoskeletal system is a highly 
plastic and adaptive system, responding quickly to chang-
ing demands [43, 80, 81]. Relatively short periods of 
immobilization decrease MPS, with no effect on MPB 
[15]. Furthermore, this altered balance is relatively resist-
ant to high dose amino acid delivery [82]. This is in con-
trast to studies in animals, in which MPB appears the 
dominant process [83, 84]. Immobilization has significant 
effects on peripheral muscle aerobic capacity [21], con-
tractility [85], insulin resistance [86] and architecture 
[87]. Microvascular dysfunction occurring in severe sep-
sis is associated with immobilization and may have an 
additive effect on reducing MPS [86, 88]. In critically ill 
patients, MPS is reduced even with nutritional delivery, 
with increased MPB seen, leading to a net catabolic state 
and thus muscle wasting [58].
Muscle wasting occurs early and rapidly in the critical 
care setting with up to 30 % of muscle mass lost within 
the first 10  days of an ICU admission [58, 89]. The rate 
of wasting for muscle thickness was fastest for the rec-
tus femoris muscle (9 %) compared to vastus intermedius 
(1 %) and vastus lateralis (0.2 %) musculature (within the 
quadriceps complex) in the first 72 h after an ICU admis-
sion [89]. The difference in the pattern of muscle wasting 
may be partly explained by the difference in functionality 
of the muscle and fibre type composition. Rectus femo-
ris is a power muscle predominantly consisting of type II 
fibres (fast twitch) whereas vastus intermedius is a deep 
mono-articular stabilizer knee extensor predominantly 
consisting of type I fibres (slow twitch) [89].
Muscle quality or echotexture deteriorates significantly 
in the first 10 days of an ICU admission with infiltration 
of non-contractile tissue such as connective tissue and 
oedema [89, 90]. Changes in the muscle quantity and 
quality using ultrasonography have been correlated with 
measures of muscle strength and function [89]. Recent 
human studies have demonstrated a reduction in muscle 
myofibre size with preferential proteolysis of the thick 
myosin filaments [91, 92] with one trial demonstrat-
ing a dramatic increase in protein degradation of up to 
160 % [92]. The same phenomenon has been observed in 
bed rest studies [93]. Finally, immobilization results in a 
loss of contractile function disproportionate to the loss 
of muscle mass [25]. Using single-fibre isolation meth-
ods, this phenomenon has been observed in critically ill 
patients [94].
Intracellular signalling in immobilization and critical illness
The signalling pathways underlying altered protein 
homeostasis in immobilization has been extensively 
studied. Immobilization upregulates E3 ligases [95] and 
other components of the ubiquitin proteasome pathway 
[96, 97]. In critically ill patients, the same pathways are 
unregulated and lead to altered protein homeostasis [58]. 
Upstream activators of the ubiquitin proteasome path-
way may exist in critical illness separate to immobiliza-
tion up-regulated pathways, which may account for the 
differences in wasting seen between models and the clini-
cal scenario. Local and systemic inflammatory processes 
in critically ill individuals may further disrupt the balance 
between muscle protein synthesis and protein break-
down, leading to a greater reduction in muscle mass [27, 
98, 99]. Increased circulating inflammatory cytokines 
(such as tumor necrosis factor-alpha (TNF-α) and inter-
leukin-1 beta (IL1-β) may also drive mitochondrial oxi-
dative stress and increase intracellular calcium [98]. This 
is postulated to trigger muscle proteolytic pathways [98, 
100] and interfere with insulin signalling, leading to ana-
bolic resistance [88], and contribute to electrophysiologi-
cal inexcitability of the muscle [101, 102].
Intramuscular metabolic pathway alterations have 
also been examined in immobilization models. Insu-
lin resistance was first described in 1959 following bed 
rest in healthy subjects [103]. The development of insu-
lin resistance subsequent to immobilization has been 
repeatedly observed [86, 104, 105]. Insulin resistance 
occurs in critical illness and immobilization may con-
tribute to this [106]. The pathogenesis of insulin resist-
ance seems similar—that of decrease in intramuscular 
glucose transporter 4 (GLUT-4) concentrations seen in 
immobilized muscle and in critically ill patients [106, 
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107]. Free reactive oxygen species and other radical spe-
cies can cause upregulation of other protein degradation 
molecules such as calpains and caspases which can cause 
sarcolemma damage and interact directly with the myo-
filament contractile function by modifying protein struc-
ture and thus affecting contractile capacity [94, 98].
A recent paper by Files and colleagues proposed mus-
cle dysfunction following critical illness could be catego-
rized into early and late stages of muscle wasting [108]. 
The early phase occurs within days of the onset of criti-
cal illness with marked muscle protein degradation and 
muscle atrophy secondary to upregulation of ubiquitin–
proteasome, autophagy and calpain-caspase pathways 
[108]. Late-phase muscle weakness refers to the ongoing 
impairment in muscle function due to ongoing disuse 
and failure to regain muscle homeostasis and pre-existing 
underlying neuromuscular deficits prior to ICU admis-
sion [108]. Whilst this is an attractive model to aid deci-
sion making regarding timings of exercise interventions 
[109], multiple barriers to early mobilization exist.
Barriers to early activity and mobilization
Although prolonged inactivity is recognized as harmful, 
current levels of activity and mobilization are low from 
point prevalence and observational data [110–112]. The 
main barriers identified include sedation, the presence 
of endotracheal tube and potential respiratory and/or 
haemodynamic instability [110–112]. One study reported 
47 % of barriers identified were due to modifiable factors 
[113]. A recent behavioural mapping study demonstrated 
patients in critical care are inactive outside of dedicated 
rehabilitation time, and individuals who were ventilated 
were 5 times more likely to be inactive [114]. All indi-
viduals in this study spent at least one-third of their day 
alone and inactive irrespective of ventilation or seda-
tion state [114]. Low-physical activity levels and muscle 
strength are associated with reduced physical function 
at intensive care discharge [115]. Although the evidence 
demonstrating early rehabilitation is safe and feasible 
[116, 117], and the development of clinical consensus 
guidelines for undertaking in-bed and out of bed active 
mobilization [118], activity levels continue to remain low. 
A significant culture change is needed and staffing and 
environmental barriers need to be considered indepen-
dently of patient-related barriers to promote early activity 
and mobilization.
Potential rehabilitation strategies to reverse effects 
of prolonged bed rest in the ICU setting
To reverse the effects of immobilization on the muscu-
loskeletal system, it is important to consider methods of 
training to enable “overload”—by placing greater demand 
on the muscle to potentially mitigate the severity of 
immobilization induced muscle wasting [24]. Considera-
tions of the specificity of training in terms of limb posi-
tion, types of training (strength, endurance, interval) 
as well as methods to artificially mimic physiologically 
induced activity are important constructs currently being 
investigated.
Assistive technology
Muscle wasting occurs early and rapidly as described ear-
lier in this review in individuals with critical illness [58]. 
There is growing interest in the use of assistive technolo-
gies, in particular supine cycle ergometry and muscle 
stimulation to commence rehabilitation early in the ICU 
admission without the need for direct patient engage-
ment [119]. In a randomized controlled trial (RCT) of 
cycle ergometry, a significant difference was seen in the 
intervention cohort for 6-min walk distance and iso-
metric quadriceps strength at hospital discharge [120]. 
Although this study demonstrated promising results 
for enhancing recovery of muscle strength and func-
tional outcomes, there was a significant delay in the time 
to commencement of the intervention—2 weeks post 
ICU admission [120]. Artificial stimulation of the skel-
etal muscles through the use of low voltage electrical 
impulses delivered through the skin to the underlying 
muscle via surface electrodes [121] is another assistive 
modality, which can be utilized without the need for 
volitional activation [122]. The efficacy for electrical 
muscle stimulation is inconclusive [122]. Finally, there is 
also growing interest in functional electrical stimulation 
assisted cycling—stimulation of multiple muscle groups 
in a functional manner facilitating cycling [123]. Prelimi-
nary research has demonstrated the safety and feasibil-
ity of this form of intervention when commenced early 
in the ICU admission period in individuals with sepsis 
[123], and a large multi-centre randomized controlled 
trial is currently in progress to determine the efficacy in 
terms of functional and cognitive recovery.
Active rehabilitation
Optimization of sedation and delirium practices is nec-
essary to enable patient engagement with active rehabili-
tation. Clinical practice guidelines have been published 
on sedation and delirium practices with consideration 
of mobilization within the bundle of care [124, 125]. 
Schweickert and colleagues published a landmark Ran-
domized Controlled Trial examining early physical and 
occupational therapy commencing within the first 48  h 
of ICU admission and demonstrated improved func-
tional recovery at hospital discharge and reduced delir-
ium duration [72]. Denehy and colleagues examined the 
efficacy of exercise rehabilitation commencing during 
the ICU admission and continuing across the continuum 
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of recovery into the outpatient setting compared to 
usual care practices [46]. There was no significant dif-
ference found in terms of 6-min walk distance results at 
12 months; however, exploratory analyses demonstrated 
the rate of change over time and mean between group 
differences were higher in the intervention cohort [46], 
and pre critical illness disease status may have been an 
unaccounted for factor [126]. The evidence for rehabilita-
tion in the ICU appears to improve quality of life, physi-
cal function and muscle strength [127]; however, the 
optimal timing, dosage and specific intervention type 
have not been elucidated.
Conclusions
Prolonged immobility is harmful with rapid reductions 
in muscle mass, bone mineral density and impairment 
in other body systems evident within the first week of 
bed rest, which is further exacerbated in individuals with 
critical illness. Therapeutic strategies to enable early 
rehabilitation and physical activity need to be developed 
alongside a culture of physical activity in the critical care 
setting. Addressing these concerns will enable a para-
digm shift from bed rest and inactivity to physical activity 
and mobility in the future.
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